Cdc16 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdc16 monoclonal antibodies for research in cell cycle regulation and mitotic processes. Cdc16 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc16, a crucial component of the anaphase-promoting complex/cyclosome (APC/C), plays a significant role in the regulation of the cell cycle by targeting specific proteins for degradation, thereby ensuring proper chromosome segregation during mitosis. The function of Cdc16 is vital for maintaining genomic stability and preventing tumorigenesis, making it an important target for cancer research. Understanding the mechanisms of Cdc16 can provide insights into cell cycle dysregulation and its implications in various diseases. Researchers can explore the complex interactions between Cdc16 and other cell cycle regulators using specific detection methods. Advanced visualization techniques help reveal the spatial and temporal dynamics of Cdc16 during different phases of mitosis. Multiple experimental approaches can be combined to build a comprehensive understanding of Cdc16's regulatory functions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge in cell cycle regulation and cancer biology.